Jinhee Kim1, Young Sam Kim2, Kyungjoo Kim3, Yeon-Mok Oh4, Kwang Ha Yoo5, Chin Kook Rhee6, Jin Hwa Lee7. 1. Department of Nursing, College of Medicine, Chosun University, Gwangju, Korea. 2. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. 3. Department of Clinical Research Support, National Strategic Coordinating Center for Clinical Research, Seoul, Korea. 4. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 5. Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea. 6. Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea. 7. Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.
Abstract
BACKGROUND: Asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is defined as having both features of asthma and COPD, which are airway hyper-responsiveness and incompletely reversible airway obstruction. However, socioeconomic impact of ACOS have not been well appreciated. METHODS: Adults with available wheezing history and acceptable spirometry were selected from the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV) in 2007-2009. Their data were merged with the Korean National Health Insurance claim data. 'Asthma group' was defined as having self-reported wheezing history and FEV1/FVC ≥0.7, 'COPD group' was defined as having FEV1/FVC <0.7 and no wheezing, 'ACOS group' was defined as having both wheezing and FEV1/FVC <0.7, and 'no airway disease (NAD) group' was defined as having no wheezing and FEV1/FVC ≥0.7. RESULTS: Among a total of 11,656 subjects, ACOS comprise 2.2%; COPD, 8.4%; asthma, 5.8% and NAD, 83.6%. Total length of healthcare utilization and medical costs of ACOS group was the top among four groups (P<0.001), though inpatient medical cost was the highest in COPD group (P=0.025). Multiple linear regression analyses showed that ACOS group (β=12.63, P<0.001) and asthma group (β=6.14, P<0.001) were significantly associated with longer duration of healthcare utilization and ACOS group (β=350,475.88, P=0.008) and asthma group (β=386,876.81, P<0.001) were associated with higher medical costs. CONCLUSIONS: This study demonstrated that ACOS independently influences healthcare utilization after adjusting several factors. In order to utilize limited medical resources efficiently, it may be necessary to find and manage ACOS patients.
BACKGROUND:Asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is defined as having both features of asthma and COPD, which are airway hyper-responsiveness and incompletely reversible airway obstruction. However, socioeconomic impact of ACOS have not been well appreciated. METHODS: Adults with available wheezing history and acceptable spirometry were selected from the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV) in 2007-2009. Their data were merged with the Korean National Health Insurance claim data. 'Asthma group' was defined as having self-reported wheezing history and FEV1/FVC ≥0.7, 'COPD group' was defined as having FEV1/FVC <0.7 and no wheezing, 'ACOS group' was defined as having both wheezing and FEV1/FVC <0.7, and 'no airway disease (NAD) group' was defined as having no wheezing and FEV1/FVC ≥0.7. RESULTS: Among a total of 11,656 subjects, ACOS comprise 2.2%; COPD, 8.4%; asthma, 5.8% and NAD, 83.6%. Total length of healthcare utilization and medical costs of ACOS group was the top among four groups (P<0.001), though inpatient medical cost was the highest in COPD group (P=0.025). Multiple linear regression analyses showed that ACOS group (β=12.63, P<0.001) and asthma group (β=6.14, P<0.001) were significantly associated with longer duration of healthcare utilization and ACOS group (β=350,475.88, P=0.008) and asthma group (β=386,876.81, P<0.001) were associated with higher medical costs. CONCLUSIONS: This study demonstrated that ACOS independently influences healthcare utilization after adjusting several factors. In order to utilize limited medical resources efficiently, it may be necessary to find and manage ACOS patients.
Authors: Chin Kook Rhee; Hyoung Kyu Yoon; Kwang Ha Yoo; Young Sam Kim; Sei Won Lee; Yong Bum Park; Jin Hwa Lee; Yuri Kim; Kyungjoo Kim; Jinhee Kim; Yeon Mok Oh; Sang Do Lee Journal: COPD Date: 2013-10-10 Impact factor: 2.409
Authors: Seung-Ji Lim; Han-Joong Kim; Chung-Mo Nam; Hoo-Sun Chang; Young Hwa Jang; Sera Kim; Hye Young Kang Journal: J Prev Med Public Health Date: 2009-07
Authors: Heidi Andersén; Pekka Lampela; Antti Nevanlinna; Olli Säynäjäkangas; Timo Keistinen Journal: Clin Respir J Date: 2013-03-20 Impact factor: 2.570
Authors: Roberto de Marco; Giancarlo Pesce; Alessandro Marcon; Simone Accordini; Leonardo Antonicelli; Massimiliano Bugiani; Lucio Casali; Marcello Ferrari; Gabriele Nicolini; Maria Grazia Panico; Pietro Pirina; Maria Elisabetta Zanolin; Isa Cerveri; Giuseppe Verlato Journal: PLoS One Date: 2013-05-10 Impact factor: 3.240
Authors: Megan Hardin; Edwin K Silverman; R Graham Barr; Nadia N Hansel; Joyce D Schroeder; Barry J Make; James D Crapo; Craig P Hersh Journal: Respir Res Date: 2011-09-27